Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-018216

President & CEO acquired 70,427 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stonehouse Jon P · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-17 Exercise or conversion : show line 1 in the form +70,427 $1.42 $100,006 725,519 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-17 Exercise or conversion : show line 2 in the form Emp. Stock Option (Right to Buy) −70,427 297,573 D
Loading xslF345X03/form4.xml…